Multiple Myeloma Specialists in Massachusetts

Daniel Deangelo, M.D.,PH.D.

Chief, Division of Leukemia Institute Physician; Professor of Medicine, Harvard Medical School

Hematology

Eric Jacobsen, MD

Associate Professor of Medicine, Harvard Medical School; Clinical Director, Adult Lymphoma Program; Director, Histiocyte Disorders Center

Hematology

Paul Richardson, MD

Director in 2001, and led the study and development of several pivotal novel drugs including thalidomide, lenalidomide, bortezomib, pomalidomide, panobinostat; Professor of Medicine at Harvard Medical School in 2012, and then became Clinical Program Leader and Director of Clinical Research in 2014.

Hematology

Kenneth Anderson, MD

Kraft Family Professor of Medicine, Harvard Medical School; Director, LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute

Oncology

Nancy Lin, MD

Professor of Medicine at Harvard Medical School, Dr. Lin’s research focuses on developing more effective therapies for patients with metastatic breast ca

Hematology

Thomas Kupper, MD

Thomas B. Fitzpatrick Professor of Dermatology; Chair, Department of Dermatology, Brigham and Women's Hospital

Hematology

Judy Garber, M.D.

Chair and Chief of the Division of Cancer Genetics and Prevention at Dana-Farber Cancer Institute and a Professor of Medicine at Harvard Medical School.&nb

Hematology

David Reardon, MD

Clinical Director, Center for Neuro-Oncology

Hematology

Andrew Brunner, M.D.

Hematology

Thomas Spitzer, MD

Professor of Medicine, Harvard Medical School; Director, Bone Marrow Transplant Program, Massachusetts General Hospital

Oncology

Tracy Batchelor, MD MPH

Hematology

Glenn Hanna, M.D.

Director of the Center for Cancer Therapeutic Innovation (CCTI), the early drug development program at DFCI. His clinical and translational research eff

Hematology

Amir Fathi, M.D.

Professor of Medicine, Harvard Medical School; Program Director, Center for Leukemia, Massachusetts General Hospital

Hematology

Nikhil Munshi, MD

Professor of Medicine, Department of Medicine, Harvard Medical School; Director of Basic and Correlative Science, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute

Oncology

Andrew Yee, M.D.

Hematology

Ronald Takvorian, MD

Assistant Professor of Medicine, Harvard Medical School

Hematology

Irene Ghobrial, M.D.

Senior Vice President for Experimental Medicine, Director of the Center for Early Detection and Interception of Blood Cancers, Co-Leader of the Lymphoma/Myeloma Cancer Center Program, Lavine Family Chair for Preventative Cancer Therapies, Director of the Ghobrial Lab, and Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School

Oncology

Matthew Frigault, MD

Hematology

Panagiotis Konstantinopoulos, M.D.

Director of the Mellen and Eisenson Family Center for BRCA and Related Genes and Director of Translational Research, Division of Gynecologic Oncology. He is a; Chair for Clinical and Translational Research at DFCI and Professor of Medicine at Harvard Medical School. His clinical and translational research career f

Hematology

Matthew Davids, M.D.

Director of Clinical Research, as well as Associate Director of the CLL Center. He is also an Associate Professor of Medicine at Harvard Medical School, and a; Director, Clinical Research, Division of Lymphoma

Hematology